Nissenson Allen 4

What Happened Nissenson Allen, a director of Rockwell Medical, Inc. (RMTI), was granted 9,633 restricted stock units (reported as an "Award/Grant" — code A) on July 1, 2026. The award was recorded at $0.00 per share (total reported value $0) because these are RSUs that convert to shares only upon vesting. The award is subject to vesting on July 1, 2027, contingent on the Reporting Person's continued service through the 2027 Annual Meeting.

Key Details

• Transaction date: July 1, 2026; Form 4 filed July 6, 2026 (this appears to be filed after the typical 2-business-day Form 4 deadline).
• Transaction type/code: Award/Grant (A) — restricted stock units (RSUs).
• Amount: 9,633 RSUs; reported acquisition price $0.00 (awarded, not purchased).
• Vesting: RSUs vest on July 1, 2027, subject to continued service through the 2027 Annual Meeting (Footnote F1).
• Reverse split: A 1-for-10 reverse split became effective 12:01 AM on July 1, 2026; outstanding equity awards and reported holdings were proportionally adjusted (Footnote F2). The Form 4 reflects those adjusted amounts.
• Shares owned after transaction: The filing reports holdings adjusted for the reverse split; the specific post-transaction beneficially owned total is not included in the excerpt provided.
• Timeliness: Filed July 6 for a July 1 transaction — appears late versus the standard 2-business-day filing window.

Context RSU grants are a form of compensation that become actual shares only if and when they vest; they are not an immediate cash purchase or sale and do not necessarily signal buying or selling intent by the insider. For retail investors, note the vesting date (July 1, 2027) — that is when the RSUs could convert to shares and potentially be sold, which would later show up as a sale on subsequent Form 4s if the insider disposes of them.